,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,1469,1,1,,29217793,2832,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
1,1471,2,1,,29217793,2832,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
2,1479,1,2,,29217793,2832,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
3,1490,2,1,,29217793,2832,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
4,1688,1,1,,29217793,2832,Inactive,90903231.0,3064.0,,Potency,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP),Confirmatory,,
5,1766,1,1,,29217793,2832,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
6,1766,1,1,,29217793,2832,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
7,1768,1,1,,29217793,2832,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
8,1768,1,1,,29217793,2832,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
9,2240,1,1,,85787231,2832,Inactive,38156699.0,4286.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of MITF,Screening,,
10,2241,1,1,,85787231,2832,Inactive,167013344.0,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1,Screening,,
11,2275,1,1,,85787231,2832,Active,,,,,Luminescence Cell-Based Primary HTS to Measure Viability of BJeLR cells,Screening,,
12,2313,1,1,,85787231,2832,Active,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of the Sonic Hedgehog Signaling Pathway,Screening,,
13,2316,1,1,,85787231,2832,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Activators of the Reversal of PD-1 Mediated Inhibitors of T-Cell Inhibition,Screening,,
14,2322,1,1,,85787231,2832,Inactive,,,,,Luminescence Homogenous Primary HTS to Identify Inhibitors of STK33 Activity,Screening,,
15,2330,1,1,,85787231,2832,Active,12830367.0,65975.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of STK33,Screening,,
16,2528,1,2,,29217793,2832,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
17,2546,1,1,,29217793,2832,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
18,2551,1,1,,29217793,2832,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
19,2662,2,1,,29217793,2832,Inactive,56550039.0,4297.0,,Potency,qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction,Confirmatory,,
20,23271,4,4,,103244665,2832,Unspecified,,,,,Partition coefficient (logD7.4),Other,2362268.0,
21,23461,3,3,,103244665,2832,Unspecified,,,,,Partition coefficient (logP),Other,7265111.0,
22,45400,3,4,,103244665,2832,Unspecified,,,,,Effect on cross resistance of CHO cells resistant to colchicine (CHRC5),Other,2362268.0,
23,120593,3,3,,103244665,2832,Unspecified,,,,,Dose of compound which caused an average weight loss >3g in a set of mice or the death of one or more of the mice in the set in the P388 NCI screen.,Other,7265112.0,
24,124468,3,3,,103244665,2832,Unspecified,,,,,Toxicity found after a single im injection. The total number of deaths were counted after 7 days and LD50 was determined by probit analysis; 200.8-279.0,Other,7265112.0,
25,140029,3,3,,103244665,2832,Unspecified,,,,,Acute toxicity after intramuscular injection in mice.,Other,2299625.0,
26,152693,4,1,,103244665,2832,Unspecified,,,,,The compound was tested for its potency against lymphocytic leukemia P388 screen in mice.,Other,7265112.0,
27,154376,3,4,,103244665,2832,Unspecified,,,,,Antitumor activity against murine lymphocytic leukemia P388 cells,Other,7265111.0,
28,214332,6,3,,103244665,2832,Active,,,2.4,IC50,Inhibitory effect on the polymerization of purified bovine brain tubulin.,Confirmatory,2299625.0,
29,214375,3,10,,103244665,2832,Unspecified,,,,,Inhibition of [3H]colchicine binding to microtubule protein tubulin,Other,7265112.0,
30,333842,6,1,,103244665,2832,Unspecified,,,,,Cytotoxicity against human KB cells,Other,7130986.0,
31,351383,6,2,,103244665,2832,Active,,,3.58,IC50,Displacement of [3H]colchicine from tubulin,Confirmatory,19394222.0,
32,351386,3,4,,103244665,2832,Active,,,,,Cytotoxicity against human K562 cells,Other,19394222.0,
33,351387,3,4,,103244665,2832,Active,,,,,Cytotoxicity against human PC3 cells,Other,19394222.0,
34,351388,3,4,,103244665,2832,Active,,,,,Cytotoxicity against human MCF7 cells,Other,19394222.0,
35,351389,3,4,,103244665,2832,Active,,,,,Cytotoxicity against human SW620 cells,Other,19394222.0,
36,351390,3,4,,103244665,2832,Active,,,,,Cytotoxicity against human HT-29 cells,Other,19394222.0,
37,351391,3,3,,103244665,2832,Inactive,,,,,Binding affinity to purine-binding protein in human red blood cells,Other,19394222.0,
38,378865,3,4,,103244665,2832,Unspecified,,,,,Antimitotic activity in human peripheral blood lymphocytes assessed as mitotic index at 1 uM,Other,10650071.0,
39,390902,3,4,,103244665,2832,Unspecified,,,,,Cell cycle arrest in human MCF7 cells assessed as accumulation at G2/M phase at 0.25 uM after 15 hrs by propidium iodide staining,Other,18778046.0,
40,390904,3,4,,103244665,2832,Unspecified,,,,,Cell cycle arrest in human MCF7 cells assessed as accumulation at G2/M phase at 0.25 uM after 15 hrs by MPM2 antibody labeling,Other,18778046.0,
41,397098,6,3,,103244665,2832,Active,,,2.4,IC50,Inhibition of bovine brain tubulin polymerization,Confirmatory,2095370.0,
42,409958,3,9,,103244665,2832,Inactive,124028637.0,281293.0,,,Inhibition of bovine brain MAOA,Other,18834112.0,
43,409960,3,9,,103244665,2832,Inactive,124028638.0,338445.0,,,Inhibition of bovine brain MAOB,Other,18834112.0,
44,434959,1,1,,85787231,2832,Inactive,,,,,Fluorescence Cell-Based Primary HTS to Measure Inhibition of Y box Binding Protein 1 Expression,Screening,,
45,485290,1,1,,29217793,2832,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
46,492961,1,1,,29217793,2832,Inactive,72386991.0,3656265.0,,Potency,qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase: hit validation,Confirmatory,,
47,504327,1,1,,29217793,2832,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
48,504332,1,1,,29217793,2832,Inactive,168985070.0,,,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
49,504749,1,3,,29217793,2832,Unspecified,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
50,504749,1,3,1.0,29217793,2832,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
51,504749,1,3,2.0,29217793,2832,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
52,504749,1,3,3.0,29217793,2832,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
53,504749,1,3,4.0,29217793,2832,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
54,504749,1,3,5.0,29217793,2832,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
55,504749,1,3,6.0,29217793,2832,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
56,504749,1,3,7.0,29217793,2832,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
57,504749,1,3,8.0,29217793,2832,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
58,504749,1,3,9.0,29217793,2832,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
59,504749,1,3,10.0,29217793,2832,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
60,504749,1,3,11.0,29217793,2832,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
61,504749,1,3,12.0,29217793,2832,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
62,504749,1,3,13.0,29217793,2832,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
63,504749,1,3,14.0,29217793,2832,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
64,504749,1,3,15.0,29217793,2832,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
65,504749,1,3,16.0,29217793,2832,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
66,504749,1,3,17.0,29217793,2832,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
67,504749,1,3,18.0,29217793,2832,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
68,504749,1,3,19.0,29217793,2832,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
69,504749,1,3,20.0,29217793,2832,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
70,504749,1,3,21.0,29217793,2832,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
71,504749,1,3,22.0,29217793,2832,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
72,504749,1,3,23.0,29217793,2832,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
73,504749,1,3,24.0,29217793,2832,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
74,504749,1,3,25.0,29217793,2832,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
75,504749,1,3,26.0,29217793,2832,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
76,504749,1,3,27.0,29217793,2832,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
77,504749,1,3,28.0,29217793,2832,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
78,504749,1,3,29.0,29217793,2832,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
79,504749,1,3,30.0,29217793,2832,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
80,504749,1,3,31.0,29217793,2832,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
81,504749,1,3,32.0,29217793,2832,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
82,504749,1,3,33.0,29217793,2832,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
83,504749,1,3,34.0,29217793,2832,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
84,504749,1,3,35.0,29217793,2832,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
85,504749,1,3,36.0,29217793,2832,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
86,504749,1,3,37.0,29217793,2832,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
87,504749,1,3,38.0,29217793,2832,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
88,504749,1,3,39.0,29217793,2832,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
89,504749,1,3,40.0,29217793,2832,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
90,504749,1,3,41.0,29217793,2832,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
91,504749,1,3,42.0,29217793,2832,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
92,504749,1,3,43.0,29217793,2832,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
93,504749,1,3,44.0,29217793,2832,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
94,504749,1,3,45.0,29217793,2832,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
95,504749,1,3,46.0,29217793,2832,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
96,504749,1,3,47.0,29217793,2832,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
97,504749,1,3,48.0,29217793,2832,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
98,504749,1,3,49.0,29217793,2832,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
99,504749,1,3,50.0,29217793,2832,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
100,504749,1,3,51.0,29217793,2832,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
101,504749,1,3,52.0,29217793,2832,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
102,504749,1,3,53.0,29217793,2832,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
103,504749,1,3,54.0,29217793,2832,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
104,504749,1,3,55.0,29217793,2832,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
105,504749,1,3,56.0,29217793,2832,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
106,504749,1,3,57.0,29217793,2832,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
107,504749,1,3,58.0,29217793,2832,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
108,504749,1,3,59.0,29217793,2832,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
109,504749,1,3,60.0,29217793,2832,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
110,504749,1,3,61.0,29217793,2832,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
111,504832,1,1,,29217793,2832,Inactive,,,,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation",Confirmatory,,
112,504834,1,1,,29217793,2832,Inactive,,,,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation",Confirmatory,,
113,504847,1,1,,29217793,2832,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
114,504865,1,1,,29217793,2832,Inactive,118600387.0,7398.0,,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
115,588579,1,1,,29217793,2832,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
116,602332,1,1,,29217793,2832,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
117,624030,1,2,,29217793,2832,Inactive,160794.0,,,Potency,Biochemical firefly luciferase enzyme assay for NPC,Confirmatory,,
118,624031,1,2,,29217793,2832,Inactive,,,,Potency,S16 Schwann cell viability assay (CellTiter-Glo assay),Confirmatory,,
119,624032,1,2,,29217793,2832,Inconclusive,8393992.0,24660.0,0.0809,Potency,S16 Schwann cell PMP22 intronic element firefly luciferase assay,Confirmatory,,
120,624044,1,2,,29217793,2832,Active,8393992.0,24660.0,0.1777,Potency,S16 Schwann cell PMP22 intronic element beta-lactamase assay,Confirmatory,,
121,624101,1,2,,85787231,2832,Inactive,62203298.0,3417.0,,,Development of  IDH1/2 inhibitors (CTD2project) Measured in Biochemical System Using Plate Reader - 2107-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
122,624136,1,1,,85787231,2832,Inactive,208342286.0,7157.0,,,mutant P53 Measured in Biochemical System Using Small Molecule MicroArray - 2077-01_Other_SinglePoint_HTS_Activity,Screening,,
123,624138,1,1,,85787231,2832,Inactive,21618340.0,6774.0,,,SMM STAT-3 Measured in Biochemical System Using Small Molecule MicroArray - 2076-01_Other_SinglePoint_HTS_Activity_Set2,Screening,,
124,624139,1,1,,85787231,2832,Inactive,34577122.0,4790.0,,,NF-KappaB Measured in Biochemical System Using Small Molecule MicroArray - 2080-01_Other_SinglePoint_HTS_Activity,Screening,,
125,624141,1,1,,85787231,2832,Inactive,71774083.0,4609.0,,,SMM c-myc Measured in Biochemical System Using Small Molecule MicroArray - 2081-01_Other_SinglePoint_HTS_Activity,Screening,,
126,624151,1,1,,85787231,2832,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Re-Activators of the P53 Mutant Pathway Measured in Cell-Based System Using Plate Reader - 2071-01_Activator_SinglePoint_HTS_Activity,Screening,,
127,624156,1,1,,85787231,2832,Inactive,,,,,Fluorescence Cell-Based Primary  HTS to Identify Reactive Oxygen Species Inducers in Cancer Cells Measured in Cell-Based System Using Plate Reader and Imaging Combination - 2044-01_Activator_SinglePoint_HTS_Activity,Screening,,
128,624170,1,1,,29217793,2832,Inactive,71051501.0,2744.0,,Potency,qHTS for Inhibitors of Glutaminase (GLS),Confirmatory,,
129,624172,1,1,,29217793,2832,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists,Confirmatory,,
130,624173,1,3,,29217793,2832,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors,Confirmatory,,
131,624296,1,1,,29217793,2832,Active,7705682.0,51053.0,0.075,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,Confirmatory,,
132,624297,1,1,,29217793,2832,Active,7705682.0,51053.0,0.1189,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Confirmatory,,
133,1053175,2,1,,178127404,2832,Inactive,,,,,A screen for compounds that inhibit growth of Escherichia coli,Other,,
134,1136875,1,1,,103244665,2832,Unspecified,,,,,Inhibition of cell cycle traverse in human HeLa cells assessed as mitotic index at 0.05 ug/ml after 16 hrs,Other,385879.0,
135,1159583,2,1,,178127404,2832,Inactive,,,,,High throughput screen for small molecule inhibitors of a hypoxia-regulated fluorescent biosensor in Mycobacterium tuberculosis,Other,,
136,1202829,1,1,,103244665,2832,Active,,,,,Cell cycle arrest in human U251 cells assessed as accumulation at G2/M phase at 3 uM after 24 hrs by DNA histogram based flow cytometry,Other,25654321.0,
137,1259309,1,1,,178127404,2832,Inactive,,,,,A screen for compounds that are lethal to S. aureus RN4220 with the processive glycosyltransferase UgtP deleted,Other,,
138,1259311,1,1,,178127404,2832,Inactive,,,,,A screen for compounds that are lethal to S. aureus RN4220,Other,,
